Beatriz Ocaña-Tienda

Ms. Beatriz Ocaña-Tienda


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 April 2023 in Scientific Data
Verified
Journal Article
Open access
PDF file
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
JPJulián Pérez-Beteta
Julián Pérez-Beteta
JVJosé D. Villanueva-García
José D. Villanueva-García
JRJosé A. Romero-Rosales
José A. Romero-Rosales
DMDavid Molina-García
David Molina-García
Víctor M. Pérez-GarcíaVíctor M. Pérez-García
Víctor M. Pérez-García
Brain metastasis (BM) is one of the main complications of many cancers, and the most frequent malignancy of the central nervous system. Imaging studies of BMs are routinely used for diagnosis of disease, treatment planning and follow-up. Artificial Intelligence (AI) has great potential to provide automated tools to assist in the management of disease. However, AI methods require large datasets for training and validation, and to date there have been just one publicly available imaging dataset of 156 BMs. This paper publishes 637 high-resolution imaging studies of 75 patients harboring 260 BM lesions, and their respective clinical data. It also includes semi-automatic segmentations of 593 BMs, including pre- and post-treatment T1-weighted cases, and a set of morphological and radiomic features for the cases segmented. This data-sharing initiative is expected to enable research into and performance evaluation of automatic BM detection, lesion segmentation, disease status evaluation and treatment planning methods for BMs, as well as the development and validation of predictive and prognostic tools with clinical applicability.

10 December 2023 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
JPJulián Pérez-Beteta
Julián Pérez-Beteta
JRJosé Antonio Romero-Rosales
José Antonio Romero-Rosales
BABeatriz Asenjo
Beatriz Asenjo
Ana Ortiz de MendivilAna Ortiz de Mendivil
Ana Ortiz de Mendivil
VPVíctor M Pérez-García
Víctor M Pérez-García
Background: The Response Assessment in Neuro-Oncology for Brain Metastases (RANO-BM) criteria are the gold standard for assessing brain metastases (BMs) treatment response. However, they are limited by their reliance on 1D, despite the routine use of high-resolution T1-weighted MRI scans for BMs, which allows for 3D measurements. Our study aimed to investigate whether volumetric measurements could improve the response assessment in patients with BMs. Methods: We retrospectively evaluated a dataset comprising 783 BMs and analyzed the response of 185 of them from 132 patients who underwent stereotactic radiotherapy between 2007 and 2021 at 5 hospitals. We used T1-weighted MRIs to compute the volume of the lesions. For the volumetric criteria, progressive disease was defined as at least a 30% increase in volume, and partial response was characterized by a 20% volume reduction. Results: Our study showed that the proposed volumetric criteria outperformed the RANO-BM criteria in several aspects: (1) Evaluating every lesion, while RANO-BM failed to evaluate 9.2% of them. (2) Classifying response effectively in 140 lesions, compared to only 72 lesions classified by RANO-BM. (3) Identifying BM recurrences a median of 3.3 months earlier than RANO-BM criteria. Conclusions: Our study demonstrates the superiority of volumetric criteria in improving the response assessment of BMs compared to the RANO-BM criteria. Our proposed criteria allow for evaluation of every lesion, regardless of its size or shape, better classification, and enable earlier identification of progressive disease. Volumetric criteria provide a standardized, reliable, and objective tool for assessing treatment response.

26 August 2024 in Cancer Imaging
Verified
Journal Article
Open access
PDF file
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
AEAlba Eroles-Simó
Alba Eroles-Simó
JPJulián Pérez-Beteta
Julián Pérez-Beteta
EAEstanislao Arana
Estanislao Arana
VPVíctor M. Pérez-García
Víctor M. Pérez-García
Background: Lung nodules observed in cancer screening are believed to grow exponentially, and their associated volume doubling time (VDT) has been proposed for nodule classification. This retrospective study aimed to elucidate the growth dynamics of lung nodules and determine the best classification as either benign or malignant. Methods: Data were analyzed from 180 participants (73.7% male) enrolled in the I-ELCAP screening program (140 primary lung cancer and 40 benign) with three or more annual CT examinations before resection. Attenuation, volume, mass and growth patterns (decelerated, linear, subexponential, exponential and accelerated) were assessed and compared as classification methods. Results: Most lung cancers (83/140) and few benign nodules (11/40) exhibited an accelerated, faster than exponential, growth pattern. Half (50%) of the benign nodules versus 26.4% of the malignant ones displayed decelerated growth. Differences in growth patterns allowed nodule malignancy to be classified, the most effective individual variable being the increase in volume between two-year-interval scans (ROC-AUC = 0.871). The same metric on the first two follow-ups yielded an AUC value of 0.769. Further classification into solid, part-solid or non-solid, improved results (ROC-AUC of 0.813 in the first year and 0.897 in the second year). Conclusions: In our dataset, most lung cancers exhibited accelerated growth in contrast to their benign counterparts. A measure of volumetric growth allowed discrimination between benign and malignant nodules. Its classification power increased when adding information on nodule compactness. The combination of these two meaningful and easily obtained variables could be used to assess malignancy of lung cancer nodules.

8 December 2022 in Neuro-Oncology Advances
Verified
Journal Article
Open access
PDF file
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
JPJulián Pérez-Beteta
Julián Pérez-Beteta
DMDavid Molina-García
David Molina-García
BABeatriz Asenjo
Beatriz Asenjo
Ana Ortiz de MendivilAna Ortiz de Mendivil
Ana Ortiz de Mendivil
Víctor M. Pérez-GarcíaVíctor M. Pérez-García
Víctor M. Pérez-García
Background: Radiation necrosis (RN) is a frequent adverse event after fractionated stereotactic radiotherapy (FSRT) or single-session stereotactic radiosurgery (SRS) treatment of brain metastases (BMs). It is difficult to distinguish RN from progressive disease (PD) due to their similarities in the magnetic resonance images. Previous theoretical studies have hypothesized that RN could have faster, although transient, growth dynamics after FSRT/SRS, but no study has proven that hypothesis using patient data. Thus, we hypothesized that lesion size time dynamics obtained from growth laws fitted with data from sequential volumetric measurements on magnetic resonance images may help in discriminating recurrent BMs from RN events. Methods: A total of 101 BMs from different institutions, growing after FSRT/SRS (60 PDs and 41 RNs) in 86 patients, displaying growth for at least 3 consecutive MRI follow-ups were selected for the study from a database of 1031 BMs. The 3 parameters of the Von Bertalanffy growth law were determined for each BM and used to discriminate statistically PDs from RNs. Results: Growth exponents in patients with RNs were found to be substantially larger than those of PD, due to the faster, although transient, dynamics of inflammatory processes. Statistically significant differences (P < .001) were found between both groups. The receiver operating characteristic curve (AUC = 0.76) supported the ability of the growth law exponent to classify the events. Conclusions: Growth law exponents obtained from sequential longitudinal magnetic resonance images after FSRT/SRS can be used as a complementary tool in the differential diagnosis between RN and PD.

15 May 2024 in Mathematical Biosciences
Verified
Journal Article
Open access
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
Víctor M. Pérez-GarcíaVíctor M. Pérez-García
Víctor M. Pérez-García
Brain metastases (BMs) are the most common intracranial tumor type and a significant health concern, affecting approximately 10% to 30% of all oncological patients. Although significant progress is being made, many aspects of the metastatic process to the brain and the growth of the resulting lesions are still not well understood. There is a need for an improved understanding of the growth dynamics and the response to treatment of these tumors. Mathematical models have been proven valuable for drawing inferences and making predictions in different fields of cancer research, but few mathematical works have considered BMs. This comprehensive review aims to establish a unified platform and contribute to fostering emerging efforts dedicated to enhancing our mathematical understanding of this intricate and challenging disease. We focus on the progress made in the initial stages of mathematical modeling research regarding BMs and the significant insights gained from such studies. We also explore the vital role of mathematical modeling in predicting treatment outcomes and enhancing the quality of clinical decision-making for patients facing BMs.

21 July 2023 in npj Systems Biology and Applications
Verified
Journal Article
Open access
PDF file
BOBeatriz Ocaña-Tienda
Beatriz Ocaña-Tienda
JPJulián Pérez-Beteta
Julián Pérez-Beteta
JJJuan Jiménez-Sánchez
Juan Jiménez-Sánchez
DMDavid Molina-García
David Molina-García
Ana Ortiz de MendivilAna Ortiz de Mendivil
Ana Ortiz de Mendivil
Víctor M. Pérez-GarcíaVíctor M. Pérez-García
Víctor M. Pérez-García
Tumor growth is the result of the interplay of complex biological processes in huge numbers of individual cells living in changing environments. Effective simple mathematical laws have been shown to describe tumor growth in vitro, or simple animal models with bounded-growth dynamics accurately. However, results for the growth of human cancers in patients are scarce. Our study mined a large dataset of 1133 brain metastases (BMs) with longitudinal imaging follow-up to find growth laws for untreated BMs and recurrent treated BMs. Untreated BMs showed high growth exponents, most likely related to the underlying evolutionary dynamics, with experimental tumors in mice resembling accurately the disease. Recurrent BMs growth exponents were smaller, most probably due to a reduction in tumor heterogeneity after treatment, which may limit the tumor evolutionary capabilities. In silico simulations using a stochastic discrete mesoscopic model with basic evolutionary dynamics led to results in line with the observed data.